Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/8/2017
SIETES contiene 91973 citas

 
 
 1 a 3 de 3 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Gargiulo G, Windecker S, da Costa BR, Feres F, Hong M-K, Gilard M, Kim H-S, Colombo A, Bhatt DL, Kim B-K, Morice M-C, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ 2016;355:i5483. [Ref.ID 100878]
2.Tiene citas relacionadas Cita con resumen
Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F, Abizaid A, Hong M-K, Kim B-K, Jang Y, Kim H-S, Park KW, Genereux P, Bhatt DL, Orlandi C, De Servi S, Petrou M, Rapezzi C, Stone GW. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. Lancet 2015;385:2371-82. [Ref.ID 99292]
3. Cita con resumen
Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto A, Botelho RV, King III SB, Negoita M, Liu M, de Paula JET, Mangione JA, Meireles GX, Castello Jr HJ, Nicolela Jr EL, Perin MA, Devito FS, Labrunie A, Salvadori Jr D, Gusmao M, Staico R, Costa Jr JR, de Castro JP, Abizaid AS, Bhatt DL, for the OPTIMIZE Trial Investigators. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 2013;310:2510-22. [Ref.ID 96672]
Seleccionar todas
 
 1 a 3 de 3